5 results
8-K
REPL
Replimune Group Inc
26 Mar 24
Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions
7:33am
, Inc. since 2002, including global launch lead and lifecycle leader for Tecentriq in lung cancer. From 1999 to 2002, Dr. Patel was Senior Consultant
8-K
EX-99.1
REPL
Replimune Group Inc
20 May 21
Replimune Reports Fiscal Fourth Quarter and Year-Ended 2021 Financial Results and Provides Corporate Update
8:06am
he was the head of their global oncology franchise for lung cancer, skin cancer and rare / agnostic tumor types, and previously the lifecycle leader
- Prev
- 1
- Next